Skip to main content
SpringerLink
Log in

Overactive Bladder

  • Chapter
  • First Online:
Postmenopausal Diseases and Disorders

  • 632 Accesses

Abstract

Overactive bladder (OAB) is a prevalent symptom syndrome that becomes more prevalent with increasing age with an unclear aetiology. OAB is often associated with the urodynamic finding of detrusor overactivity. Symptoms include urinary urgency, frequency and nocturia and may or not be associated with urinary incontinence. The condition is known to have a significant impact on quality of life. Assessment of OAB requires a thorough assessment of patients’ medical history, examination and severity assessment before commencing treatment.

Treatment of OAB is often multimodal with lifestyle changes and pharmacotherapy. Refractory OAB can be described as failure to respond to medical management of OAB. Alternative second-line treatments with intra-vesical injections of botulinum A toxin and neuromodulation methods can be highly effective however are invasive and expensive and can require long-term follow-up with top-up treatments. In absolute refractory cases, surgery can be considered. These are discussed further.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21:5–26.

    Article  Google Scholar 

  2. Coyne KS, Sexton CC, Irwin DE, Kopp ZS, Kelleher CJ, Milsom I. The impact of overactive bladder, incontinence and other lower urinary tract symptoms on quality of life, work productivity, sexuality and emotional well-being in men and women: results from the EPIC study. BJU Int. 2008;101:1388–95.

    Article  Google Scholar 

  3. Stewart WF, Corey R, Herzog AR, et al. Prevalence of overactive bladder in women. Results from the NOBLE programme. Int Urogynaecol J. 2001;12:S66.

    Google Scholar 

  4. Hakimi S, Aminian E, Charandabi SMA, et al. Risk factors of overactive bladder syndrome and its relation to sexual function in menopausal women. Urologia J. 2018;85:10–4.

    Article  Google Scholar 

  5. Portman DJ, Gass ML. Vulvovaginal Atrophy Terminology Consensus Conference Panel: Genitourinary syndrome of menopause: new terminology for vulvovaginal atrophy from the International Society for the Study of Women’s Sexual Health and The North American Menopause Society. Maturitas. 2014;79:349–54.

    Article  CAS  Google Scholar 

  6. Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis. 1999;28:723–72.

    Article  CAS  Google Scholar 

  7. Balachandran AA, Wildman SS, Strutt M, Duckett J. Is chronic urinary infection a cause of overactive bladder? Eur J Obstet Gynecol Reprod Biol. 2016;201:108–12.

    Article  Google Scholar 

  8. Corcos J, Przydacz M, Campeau L, et al. CUA guideline on adult overactive bladder. Can Urol Assoc J. 2017;11(5):E142–73.

    Article  Google Scholar 

  9. Hessdoerfer E, Jundt K, Peschers U. Is a dipstick test sufficient to exclude urinary tract infection in women with overactive bladder? Int Urogynecol J. 2011;22:229–32.

    Article  Google Scholar 

  10. Cutner A. Uroflowmetry. In: Cardozo L, editor. Urogynaecology. London: Churchill Livingstone; 1997. p. 109–16.

    Google Scholar 

  11. Henry Lai H, Rawal A, Shen B, Vetter J. The relationship between anxiety and overactive bladder/urinary incontinence symptoms in the clinical population. Urology. 2016;98:50–7.

    Article  Google Scholar 

  12. Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR. Depressive disorders and the menopause transition. Maturitas. 2012;71(2):120–30.

    Article  Google Scholar 

  13. Shy M, Fletcher SG. Objective evaluation of overactive bladder: which surveys should I use? Curr Bladder Dysfunct Rep. 2013;8(1):45–50. https://doi.org/10.1007/s11884-012-0167-2.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Vij M, Srikrishna S, Robinson D, Cardozo L. Quality assurance in quality of life assessment—measuring the validity of the King’s Health Questionnaire. Int Urogynecol J. 2014;25(8):1133–5.

    Article  CAS  Google Scholar 

  15. Hashim M, Abrams P. Is the bladder a reliable witness for predicting detrusor overactivity? J Urol. 2006;175:191–5.

    Article  CAS  Google Scholar 

  16. Liedl B, Goeschen K, Sutherland SE, Roovers JP, Yassouridis A. Can surgical reconstruction of vaginal and ligamentous laxity cure overactive bladder symptoms in women with pelvic organ prolapse? BJU Int. 2019;123(3):493–510.

    Article  Google Scholar 

  17. Robinson D, Giarenis I, Cardozo L. You are what you eat: the impact of diet on overactive bladder and lower urinary tract symptoms. Maturitas. 2014;79(1):8–13.

    Article  CAS  Google Scholar 

  18. Majumdar A, Hassan I, Saleh S, et al. Inpatient bladder retraining: is it beneficial on its own? Int Urogynecol J Pelvic Floor Dysfunct. 2010;21:657–63.

    Article  Google Scholar 

  19. Geller EJ, Crane AK, Wells EC, et al. Effect of anticholinergic use for the treatment of overactive bladder on cognitive function in post-menopausal women. Clin Drug Investig. 2012;32(10):697–705.

    Article  CAS  Google Scholar 

  20. Cardozo L. Systematic review of overactive bladder therapy in females. Can Urol Assoc J. 2011;5(5 Suppl 2):S139–42. https://doi.org/10.5489/cuaj.11185.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Smith A, Bevan D, Douglas HR, James D. Management of urinary incontinence in women: summary of updated NICE guidance. BMJ. 2013;347:f5170.

    Article  Google Scholar 

  22. Nitti VW, Khullar V, Kerrebroeck P, et al. Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies. Int J Clin Pract. 2013;67(7):619–32.

    Article  CAS  Google Scholar 

  23. Jayarajan J, Radomski SB. Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life. Res Rep Urol. 2014;6:1–16.

    Google Scholar 

  24. Cody JD, Jacobs ML, Richardson K, Moehrer B, Hextall A. Oestrogen therapy for urinary incontinence in post-menopausal women. Cochrane Database Syst Rev. 2012;(10):CD001405.

    Google Scholar 

  25. Lethaby A, Ayeleke RO, Roberts H. Local oestrogen for vaginal atrophy in postmenopausal women. Cochrane Database Syst Rev. 2016;(8):CD001500.

    Google Scholar 

  26. Simunić V, Banović I, Ciglar S, et al. Local Oestrogen treatment in patients with urogenital symptoms. Int J Gynaecol Obstet. 2003;82(2):187–97.

    Article  Google Scholar 

  27. Matarazzo MG, Caruso S, Giunta G, Valenti G, Sarpietro G, Cianci A. Does vaginal estriol make urodynamic changes in women with overactive bladder syndrome and genitourinary syndrome of menopause? Eur J Obstet Gynecol Reprod Biol. 2018;222:75–9.

    Article  CAS  Google Scholar 

  28. Rufford J, Hextall A, Cardozo L, et al. A double-blind placebo-controlled trial on the effects of 25 mg estradiol implants on the urge syndrome in postmenopausal women. Int Urogynecol J. 2003;14:78.

    Article  Google Scholar 

  29. Robinson D, Cardozo L. Urogynaecology: urinary incontinence. In: Edmunds K, editor. Dewhursts textbook of obstetrics and gynaecology. 8th edn. London: Wiley-Blackwell; 2012. p. 109–116 (Churchill Livingstone. p. 1997).

    Chapter  Google Scholar 

  30. Wein AJ. Diagnosis and treatment of the overactive bladder. Urology. 2003;62:20–7.

    Article  Google Scholar 

  31. Schurch B, Stohrer M, Kramer G, Schmid DM, Gaul G, Hauri D. Botulinum-A toxin for treating detrusor hyperreflexia in spinal cord injured patients: a new alternative to anticholinergic drugs? Preliminary results. J Urol. 2000;164:692–7.

    Article  CAS  Google Scholar 

  32. Wong J, Tincello DG, Management of refractory overactive bladder. Obstet Gynaecol. 2016;18:173–81.

    Google Scholar 

  33. Miotla P, Cartwright R, Skorupska K, et al. Urinary retention in female OAB after intravesical Botox injection: who is really at risk? Int Urogynecol J. 2017;28(6):845–50.

    Article  Google Scholar 

  34. de Wall LL, Heesakkers JPFA. Effectiveness of percutaneous tibial nerve stimulation in the treatment of overactive bladder syndrome. Res Rep Urol. 2017;9:145–57.

    PubMed  PubMed Central  Google Scholar 

  35. Peters KM, Carrico DJ, Wooldridge LS, Miller CJ, MacDiarmid SA. Percutaneous tibial nerve stimulation for the long-term treatment of overactive bladder: 3-year results of the STEP study. J Urol. 2013;189:2194–201.

    Article  Google Scholar 

  36. Brazzelli M, Murray A, Fraser C. Efficacy and safety of sacral nerve stimulation for urinary urge incontinence: a systematic review. J Urol. 2006;175:835–41.

    Article  Google Scholar 

  37. Veeratterapillay R, Thorpe AC, Harding C. Augmentation cystoplasty: contemporary indications, techniques and complications. Indian J Urol. 2013;29(4):322–7.

    Article  Google Scholar 

  38. Moon A, Vasdev N, Thorpe AC. Continent urinary diversion. Indian J Urol. 2013;29(4):303–9.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urogynaecology, Imperial College NHS Trust, London, UK

    Visha K. Tailor & G. Alessandro Digesu

Authors
  1. Visha K. Tailor
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. G. Alessandro Digesu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to G. Alessandro Digesu .

Editor information

Editors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Zaragoza Facultad de Medicina, Zaragoza, Spain

    Faustino R. Pérez-López

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tailor, V.K., Digesu, G.A. (2019). Overactive Bladder. In: Pérez-López, F. (eds) Postmenopausal Diseases and Disorders. Springer, Cham. https://doi.org/10.1007/978-3-030-13936-0_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-13936-0_8

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-13935-3

  • Online ISBN: 978-3-030-13936-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation